Nick Sather

Nick Sather is a scientist and entrepreneur who co-founded Amphix Bio, Inc., a company developing regenerative medicine therapies.12 He currently serves as the Chief Executive Officer of Amphix Bio, a position he has held since 2022.1 Prior to becoming CEO, Sather was the Co-founder and Chief Development Officer of the company from 2019 to 2022.1

Professional Background

Sather has a strong background in scientific research and development. His career includes:

• Associate Director for Translational Research & Technology Transfer at Simpson Querrey Institute @ Northwestern University (October 2022 - Present)1
• Postdoctoral Fellow at Northwestern University (January 2019 - September 2020)1
• PhD Researcher at Northwestern University (September 2013 - December 2018)1

Education

Sather's educational background includes:

• Doctor of Philosophy (Ph.D.) in Materials Science & Engineering from Northwestern University (2013 - 2018)1
• Bachelor of Science (B.S.) in Materials Science & Engineering and Physics from Massachusetts Institute of Technology (2009 - 2013)1

Amphix Bio

Under Sather's leadership, Amphix Bio has made significant progress in developing regenerative therapies:

• The company recently secured a $1M Small Business Innovation Research (SBIR) Phase II grant from the National Science Foundation to scale up manufacturing methods for its platform technology.2
• Amphix Bio's technology focuses on supramolecular peptide therapeutics that signal the patient's own cells to initiate regenerative processes.2
• Their lead product, an off-the-shelf implant for spinal fusion surgeries, has been designated as a Breakthrough Device by the FDA for treating back pain caused by degenerative disc disease.2

Sather has expressed enthusiasm for the company's technology, stating, "Our technology can offer a simpler and safer solution for treating debilitating back pain, without the side effects associated with harvesting autograft tissue or using recombinant proteins to induce bone growth".2